GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: compound 11c [PMID: 2617910] | Ro 09-4889
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: RO0094889 is a prodrug dihydropyrimidine dehydrogenase (DPD) inhibitor that was developed by Hoffmann-La Roche [3]. RO0094889 is metabolised by enzymes secreted by tumours to produce the DPD inhibitor 5-vinyluracil. This leads to inhibition of DPD-mediated catabolic degradation of the 5-fluorouracil produced locally in tumours from capecitabine [2]. RO0094889 is orally active.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| IUPAC Name  | 
| [(2R,3R,4R,5R)-4-acetyloxy-5-(4-amino-5-ethenyl-2-oxopyrimidin-1-yl)-2-methyloxolan-3-yl] acetate | 
| Synonyms  | 
| compound 11c [PMID: 2617910] | Ro 09-4889 | 
| Database Links  | |
| GtoPdb PubChem SID | 387065596 | 
| PubChem CID | 9840745 | 
| Search Google for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N | 
| Search Google for chemicals with the same backbone | NELWQUQCCZMRPB | 
| UniChem Compound Search for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | NELWQUQCCZMRPB-UBPLGANQSA-N |